Kazuhiro Yoshiuchi

Associate Professor

The Univeristy of Tokyo
Country flagJapan
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (5)

Background While behavioral interventions remain an evidence-based treatment for obesity, they often require long durations and frequent sessions. To address this, we hypothesized that interventions delivered in daily life via a smartphone app combined with personalized optimization using reinforcement learning may effectively support behavior changes. Objective This study aimed to develop and evaluate the feasibility of such an app for individuals with obesity. Methods We developed a smartphone app to assist in setting and reviewing daily behaviors related to weight loss. On the screen on which daily behaviors were shown, the order of presentation was optimized using Thompson sampling, a multiarmed bandit algorithm. Twenty individuals with obesity used the app for 4 weeks, and the daily app use rates were quantified. Body weight and mood status were measured daily during the study, and a brief-type self-administered diet history questionnaire and the International Physical Activity Questionnaire were administered at the beginning and end of the study. Changes in these measures were evaluated using the Wilcoxon signed rank test. Furthermore, the longitudinal data collected during this study were analyzed using a linear mixed-effects model to examine factors related to the number of behaviors performed daily. Results All 20 recruited individuals with obesity completed the 4-week study schedule. The median app use rate was 98.3% (range 76.9%‐100%). Significant improvements were observed in BMI (median at start 34.9 kg/m 2 , range 27.4-52.9; median at end 34.1 kg/m 2 , range 26.7‐51.0; P =.01), as well as daily energy intake and weekend sitting time. The linear mixed-effects model showed a significant association between higher preceding depressive mood levels and fewer behaviors ( P <.001). Conclusions The feasibility of the smartphone app using reinforcement learning for obesity was sufficient, and the potential effectiveness of the treatment was suggested. Preceding depressive mood may influence daily behaviors related to weight loss.

Year:

2026

Background The prolonged COVID-19 pandemic has significantly affected the clinical care and the mental health of patients in psychosomatic medicine. Between late 2021 and early 2022, the Japanese Society of Psychosomatic Medicine (JSPM) and the Japanese Society of Psychosomatic Internal Medicine (JSPIM) conducted a nationwide physician survey to assess these effects. The survey identified difficulties in outpatient and inpatient care, increased use of telemedicine, and rises in patient numbers and symptom severity. Due to inconsistent findings in prior studies on long-term mental health effects of the pandemic, a follow-up survey was needed. Methods This study is the one-year follow-up survey conducted by JSPM and JSPIM. A cross-sectional, web-based survey was conducted among physicians of the two societies from December 21, 2022, to February 14, 2023. The questionnaire examined trends in outpatient and inpatient care, telemedicine use, and changes in the mental health of patients with psychosomatic disorders, eating disorders, adjustment disorders, mood disorders, and anxiety disorders. Descriptive statistical analyses were performed. Results A total of 251 physicians responded. While outpatient numbers showed partial recovery, 28% of the respondents reported persistent declines compared to pre-pandemic levels. Telemedicine remained in use at 62% of their institutions, but 70% of the respondents reported difficulties in symptom assessment. Compared to the previous year, more respondents reported an increase in the number of patients across all surveyed disorders. Regarding the psychosocial factors that affected patients, fear of infection was the predominant factor for anxiety disorders, as in the previous survey, whereas restrictions on daily and social activities were the most influential for psychosomatic disorders, mood disorders, and adjustment disorders. Conclusions The COVID-19 pandemic has had a lasting effect on patients receiving psychosomatic treatment. Outpatient numbers are gradually recovering, and telemedicine has contributed to the continuity of care. However, concerns about patient assessment in telemedicine persist. The impact of the prolonged pandemic on mental health appears to have evolved, with shifts in the psychosocial factors that influence different aspects of mental health deterioration. Future studies that incorporate clinical data will provide valuable insights into the long-term consequences of the pandemic and help guide future clinical practice.

Year:

2025

Background Individuals with type 2 diabetes and eating disorders must change their eating behaviors, which are often influenced by psychological factors like depression and anxiety. To efficiently assess daily psychological status, the present study aimed to develop computerized adaptive tests (CAT) based on item response theory (IRT). Methods Individuals with depression, anxiety disorders, eating disorders, type 2 diabetes, and healthy persons participated in the study. Participants completed six questionnaires, including momentary and most recent one-week depression, anxiety, and positive affect. We selected items meeting the IRT assumptions, applied a graded response model, and conducted CAT simulations. Results Across all six questionnaires, the CAT simulations used a smaller number of items and exhibited substantial Pearson’s correlation coefficients exceeding 0.95 between simulated and full item-set mood status estimates. These estimated mood scores demonstrated satisfactory concurrent validity with the Hospital Anxiety and Depression Scale and sufficient discriminant validity between the clinical group and healthy controls. Conclusion These findings suggest that these scales offer efficient measurement of the mood status of individuals with an eating disorder or type 2 diabetes.

Year:

2025

BACKGROUND The field of mental health technology presently has significant gaps that need addressing, particularly in the domain of daily monitoring and personalized assessments. Current noninvasive devices such as wristbands and smartphones are capable of collecting a wide range of data, which has not yet been fully used for mental health monitoring. OBJECTIVE This study aims to introduce a novel dataset for personalized daily mental health monitoring and a new macro-micro framework. This framework is designed to use multimodal and multitask learning strategies for improved personalization and prediction of emotional states in individuals. METHODS Data were collected from 298 individuals using wristbands and smartphones, capturing physiological signals, speech data, and self-annotated emotional states. The proposed framework combines macro-level emotion transformer embeddings with micro-level personalization layers specific to each user. It also introduces a Dynamic Restrained Uncertainty Weighting method to effectively integrate various data types for a balanced representation of emotional states. Several fusion techniques, personalization strategies, and multitask learning approaches were explored. RESULTS The proposed framework was evaluated using the concordance correlation coefficient, resulting in a score of 0.503. This result demonstrates the framework’s efficacy in predicting emotional states. CONCLUSIONS The study concludes that the proposed multimodal and multitask learning framework, which leverages transformer-based techniques and dynamic task weighting strategies, is superior for the personalized monitoring of mental health. The study indicates the potential of transforming daily mental health monitoring into a more personalized app, opening up new avenues for technology-based mental health interventions. CLINICALTRIAL

Year:

2024

Purpose Delirium is a common and serious comorbidity in patients with advanced cancer, necessitating effective management. Nonetheless, effective drugs for managing agitated delirium in patients with advanced cancer remain unclear in real-world settings. Thus, the present study aimed to explore an effective pharmacotherapy for this condition. Methods We conducted a secondary analysis of a multicenter prospective observational study in Japan. The analysis included patients with advanced cancer who presented with agitated delirium and received pharmacotherapy. Agitation was defined as a score of the Richmond Agitation-Sedation Scale for palliative care (RASS-PAL) of ≥ 1. The outcome was defined as -2 ≤ RASS-PAL ≤ 0 at 72 h after the initiation of pharmacotherapy. Multiple propensity scores were quantified using a multinomial logistic regression model, and adjusted odds ratios (ORs) were calculated for haloperidol, chlorpromazine, olanzapine, quetiapine, and risperidone. Results The analysis included 271 patients with agitated delirium, and 87 (32%) showed -2 ≤ RASS-PAL ≤ 0 on day 3. The propensity score-adjusted OR of olanzapine was statistically significant (OR, 2.91; 95% confidence interval, 1.12 to 7.80; P = 0.030). Conclusions The findings suggest that olanzapine may effectively improve delirium agitation in patients with advanced cancer.

Year:

2024

Collaborators (5)

Akifumi Kishi

Associate Professor

The Univeristy of Tokyo

JAPAN
View details

toru nakamura

Professor

Osaka University

JAPAN
View details

Yoshiharu Yamamoto

University of Tokyo

JAPAN
View details

Toshimasa Yamauchi

Professor

Graduate School of Medicine, The University of Tokyo

JAPAN
View details

Björn Schuller

Full Professor

Imperial College London

UNITED KINGDOM
View details